Shanmugam Muthusamy 4

What Happened Shanmugam Muthusamy, Head of R&D, COO—Novitium Ops, and a company director at ANI Pharmaceuticals (ANIP), was granted 11,116 restricted shares on February 26, 2026. The award is recorded at $77.15 per share for a total reported value of $857,599. This was an award/acquisition (code A) — an equity grant rather than an open-market purchase or sale.

Key Details

• Transaction date and price: 11,116 shares on 2026-02-26 at $77.15 per share (total $857,599).
• Transaction type: Restricted stock award (SEC Form 4 code A).
• Vesting: The award vests in four equal annual installments on the first, second, third and fourth anniversaries of February 26, 2026 (Footnote F1).
• Shares owned after transaction: Not specified in the provided filing excerpt.
• Control notes: Reporting person holds voting and dispositive power over shares held by Esjay LLC and SS Pharma LLC (Footnotes F2, F3).
• Filing timeliness: Form filed 2026-03-02 for a 2026-02-26 grant; this filing date meets the typical 2-business-day Form 4 deadline and is not indicated as late.

Context Restricted stock awards are compensation grants that vest over time; they represent an acquisition of company equity for the insider but are subject to future vesting conditions. This transaction increases the insider’s potential stake but does not involve an immediate sale, so it’s a compensation-related grant rather than a market-driven purchase or disposition.